Streetbeat News

Regulatory

AKTX

Akari Therapeutics, Plc (NASDAQ:AKTX) has announced a change in the ratio of its American Depositary Shares (ADSs) to ordinary shares from 1:100 to 1:2000, effective from August 17, 2023. The change is aimed at regaining compliance with the Nasdaq minimum bid price requirement. Deutsche Bank will manage the exchange of current ADSs for new ones. No fractional new ADSs will be issued, instead, fractional entitlements will be sold and the proceeds distributed to the applicable ADS holders.

Portfolio Pulse from Happy Mohamed

August 15, 2023 | 12:07 pm

CYBN

Cybin Inc. has been granted a U.S. patent for its proprietary deuterated psilocybin analog in the CYB003 program. The patent covers composition of matter claims and treatment methods until 2041. The company's intellectual property portfolio now includes 2 granted U.S. patents and over 50 pending patent applications across 6 patent families. CYB003 is currently being evaluated in a Phase 2 clinical trial for the treatment of major depressive disorder. The company expects to report topline Phase 2 efficacy data for CYB003 in Q3/Q4 2023.

Portfolio Pulse from Happy Mohamed

August 15, 2023 | 12:00 pm

A Russian court has frozen the local assets of Credit Suisse, according to TASS. The details of the case and the potential impact on Credit Suisse's operations are not specified.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2023 | 11:46 am

SXTP

60 Degrees Pharmaceuticals has registered a Phase IIB study of Tafenoquine for the treatment of COVID-19 on ClinicalTrials.gov. The study is named ACLR8-LR.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2023 | 11:32 am

GLTO

Trading of Galecto's shares has been temporarily halted due to pending news.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2023 | 11:26 am

DCTH

Delcath Systems announced that the FDA has approved its HEPZATO KIT for the treatment of adult patients with unresectable hepatic-dominant metastatic uveal melanoma. Following the announcement, the company's shares surged by 69% in premarket trading.

Portfolio Pulse from Charles Gross

August 15, 2023 | 11:12 am

TLSA

The FDA has cleared Tiziana Life Sciences' Investigational New Drug Application for intranasal Foralumab to be studied in Alzheimer's disease. This is a significant step for Tiziana Life Sciences as it allows the company to proceed with clinical trials.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2023 | 11:03 am

FOLD

Amicus Therapeutics has announced the approval and launch of its new Pompe disease therapy in the United Kingdom. This could potentially increase the company's market share and revenues.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2023 | 11:02 am

CALT

DFS

DSGN

FRHC

GETY

GOL

HRYU

HTH

VNO

Several US-listed stocks traded lower in Tuesday's pre-market session. Design Therapeutics fell 37.9% after reporting Q2 results and initial results from a Phase 1 study. Getty Images declined 18.6% after reporting Q2 earnings. Freedom Holding fell 12.8% after receiving a Nasdaq noncompliance notification. Sea Limited fell 11.7% following weaker-than-expected quarterly results. Calliditas Therapeutics fell 7.8% after announcing full results from a Phase 3 trial. Kanzhun, Hanryu Holdings, Discover Financial Services, Hilltop Holdings, Vornado Realty Trust, and Gol Linhas Aéreas Inteligentes also recorded losses.

Portfolio Pulse from Lisa Levin

August 15, 2023 | 11:00 am

GOOG

GOOGL

GM Cruise's autonomous vehicles caused a traffic jam on Vallejo Street in California due to issues with cellphone carriers. The incident occurred shortly after California extended driverless robotaxi operations around the clock. Cruise, a unit of General Motors (NYSE:GM), attributed the disruption to the impact of a music festival on LTE cell connectivity. The California Public Utilities Commission recently granted Alphabet Inc's (NASDAQ:GOOG) (NASDAQ:GOOGL) Waymo and Cruise permission to operate autonomous vehicles with paying passengers throughout the day.

Portfolio Pulse from Anan Ashraf

August 15, 2023 | 10:21 am